1. Home
  2. NXL vs AACG Comparison

NXL vs AACG Comparison

Compare NXL & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • AACG
  • Stock Information
  • Founded
  • NXL 2010
  • AACG 1999
  • Country
  • NXL United States
  • AACG China
  • Employees
  • NXL N/A
  • AACG N/A
  • Industry
  • NXL Medical Specialities
  • AACG Other Consumer Services
  • Sector
  • NXL Health Care
  • AACG Real Estate
  • Exchange
  • NXL Nasdaq
  • AACG Nasdaq
  • Market Cap
  • NXL 21.0M
  • AACG 24.4M
  • IPO Year
  • NXL 2022
  • AACG N/A
  • Fundamental
  • Price
  • NXL $0.98
  • AACG $0.86
  • Analyst Decision
  • NXL Strong Buy
  • AACG
  • Analyst Count
  • NXL 1
  • AACG 0
  • Target Price
  • NXL $5.00
  • AACG N/A
  • AVG Volume (30 Days)
  • NXL 87.1K
  • AACG 11.8K
  • Earning Date
  • NXL 08-07-2025
  • AACG 08-06-2025
  • Dividend Yield
  • NXL N/A
  • AACG N/A
  • EPS Growth
  • NXL N/A
  • AACG N/A
  • EPS
  • NXL N/A
  • AACG N/A
  • Revenue
  • NXL $131,065.00
  • AACG $37,997,003.00
  • Revenue This Year
  • NXL $79.59
  • AACG N/A
  • Revenue Next Year
  • NXL $334.65
  • AACG N/A
  • P/E Ratio
  • NXL N/A
  • AACG N/A
  • Revenue Growth
  • NXL N/A
  • AACG 21.24
  • 52 Week Low
  • NXL $0.59
  • AACG $0.50
  • 52 Week High
  • NXL $4.49
  • AACG $1.10
  • Technical
  • Relative Strength Index (RSI)
  • NXL 35.46
  • AACG 54.98
  • Support Level
  • NXL $0.95
  • AACG $0.83
  • Resistance Level
  • NXL $1.03
  • AACG $0.86
  • Average True Range (ATR)
  • NXL 0.08
  • AACG 0.03
  • MACD
  • NXL 0.00
  • AACG 0.01
  • Stochastic Oscillator
  • NXL 29.03
  • AACG 99.91

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About AACG ATA Creativity Global

ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.

Share on Social Networks: